Gabapentin Tablet
Product Images NDC 63629-8492
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
The text describes a graph displaying the results of a study evaluating different doses of gabapentin and a placebo in the treatment of pain. The study includes a fixed dose period of 4 weeks and the graph shows the mean pain score over this period. The x-axis indicates the weeks, while the y-axis represents the pain score. The study includes three dose variations of gabapentin and a placebo group. The doses of gabapentin used were 0 mg/day, 1800 mg/day, and 2400 mg/day. The graph shows that the higher doses of gabapentin resulted in a lower mean pain score compared to the placebo group.*
Figure 3 (Image 03)
Image-04 (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
Label (Lbl636298492)
Gabapentin Tablets USP are film-coated tablets that contain 600 mg of gabapentin, USP. This medication should be stored between 20-25°C, with permitted excursions to 15-30°C. It must be kept out of the reach of children and dispensed in a tight container as defined in the USP with a child-resistant closure. The product is manufactured by BRP Pharmaceuticals and comes in a packet of 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.